Ischemic heart disease Flashcards

1
Q

What is Ischemic Heart Disease (IHD)?

A

A condition where there is an inadequate supply of blood and oxygen to a part of the myocardium due to an imbalance between myocardial oxygen supply and demand. It is also known as Coronary Artery Disease (CAD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main cause of IHD?

A

Mainly caused by atherosclerosis of the coronary artery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How many people did CAD affect globally in 2015, and how many deaths did it cause?

A

CAD affected 110 million people and resulted in 8.9 million deaths, accounting for 15.9% of all global deaths.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does atherosclerosis affect different organs?

A

In the heart, it leads to angina, MI, and sudden death; in the brain, it causes stroke and transient ischemic attack; in the limbs, it causes claudication and critical limb ischemia; in the kidneys, it narrows arteries, reducing blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the progression of atherosclerosis?

A

It is a progressive inflammatory disorder with lipid-rich deposits (atheroma) in the arterial wall, which can remain asymptomatic until it disrupts tissue perfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the non-modifiable risk factors for atherosclerosis?

A

Age, male sex, and positive family history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are men at higher risk of atherosclerosis than women?

A

Men have lower estrogen levels, which increases LDL (bad cholesterol) and reduces HDL (good cholesterol), making them more susceptible to atherosclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does nitric oxide affect blood vessels?

A

Nitric oxide relaxes endothelium in blood vessels, aiding in vasodilation and blood flow regulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the modifiable risk factors for atherosclerosis?

A

Smoking, hypertension, diabetes mellitus, hypercholesterolemia, obesity, physical inactivity, and alcohol use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How does smoking increase atherosclerosis risk?

A

Smoking increases inflammation, leading to LDL deposition, physical stress on arteries, and increased platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the symptoms of angina?

A

Symptoms include central/retrosternal chest pain described as “heavy,” “tight,” or “gripping,” and may range from mild ache to severe pain with sweating and fear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Prinzmetal’s angina, and who is more likely to experience it?

A

Prinzmetal’s angina is caused by artery spasms, typically at rest, and is more common in women.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the classifications of angina according to the Canadian Cardiovascular Society?

A

Angina is classified as follows: 1. Typical angina: all three main features 2. Atypical angina: two out of three features 3. Non-anginal chest pain: one or less features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between typical, atypical, and non-anginal chest pain?

A

Typical angina meets all three criteria, atypical angina meets two, and non-anginal chest pain meets one or none of these criteria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the types of angina?

A
  1. Stable Angina - occurs with activity or stress 2. Unstable Angina - occurs at rest, increases in frequency and severity 3. Refractory Angina - chronic angina unresponsive to treatment 4. Prinzmetal’s Angina - caused by a spasm in the coronary arteries, typically at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is stable angina characterized?

A

By central chest pain, discomfort, or breathlessness triggered by exertion or stress, relieved by rest.

17
Q

What activities commonly precipitate angina?

A

Physical exertion, cold exposure, heavy meals, and intense emotion. Less commonly, lying flat (decubitus angina) and vivid dreams (nocturnal angina) can trigger it.

18
Q

What is the significance of a 6–8-hour nitrate-free period in angina management?

A

This period prevents pharmacological tolerance to nitrates, maintaining their effectiveness.

19
Q

Why is lying down a possible trigger for angina?

A

Lying down (decubitus angina) increases venous return to the heart, potentially raising myocardial oxygen demand and triggering angina in susceptible individuals.

20
Q

What are common findings in a resting ECG of a patient with angina?

A

Often normal but may show reversible ST segment depression or elevation with or without T-wave inversion during symptoms.

21
Q

What are the main types of investigations for diagnosing IHD?

A

Resting ECG, exercise ECG, and coronary arteriography.

22
Q

What is the purpose of an ECG in diagnosing IHD?

A

To detect reversible ST segment depression or elevation, and T-wave inversion during symptoms.

23
Q

What is the purpose of coronary arteriography?

A

Provides detailed anatomical information on the extent and nature of coronary artery disease, especially when non-invasive tests do not confirm the cause of chest pain.

24
Q

What are antianginal drugs used in managing IHD?

A

Five main types: nitrates, beta-blockers, calcium antagonists, antiplatelet agents, and statins.

25
Q

How does glyceryl trinitrate relieve angina?

A

It acts on vascular smooth muscle to produce venous and arteriolar dilatation, reducing myocardial oxygen demand and relieving angina symptoms.

26
Q

How do beta-blockers help in managing IHD?

A

They reduce myocardial oxygen demand by lowering heart rate, blood pressure, and myocardial contractility.

27
Q

How do calcium channel blockers work in managing IHD?

A

They block calcium entry into vascular and myocardial cells, promoting vasodilation and reducing blood pressure and myocardial oxygen demand.

28
Q

What is the role of antiplatelet therapy in CAD?

A

To reduce the risk of adverse events like myocardial infarction, often using aspirin or clopidogrel.

29
Q

How does aspirin benefit patients with CAD?

A

Low-dose aspirin reduces the risk of adverse events like myocardial infarction by inhibiting platelet aggregation.

30
Q

What are the benefits of statins in CAD management?

A

Statins lower LDL cholesterol levels in the blood, reducing the risk of plaque buildup in arteries.

31
Q

What is the mechanism of potassium channel activators in IHD treatment?

A

They promote potassium efflux, hyperpolarize cell membranes, prevent calcium influx, reduce cardiac afterload, and increase coronary blood flow.

32
Q

What is the role of ivabradine in IHD management?

A

Ivabradine is an If channel antagonist that reduces heart rate without significantly affecting blood pressure, suitable for patients with heart failure.

33
Q

What is the recommended initial medical management for angina?

A

Start with low-dose aspirin, a statin, nitroglycerin (sublingual GTN), and a beta-blocker; add a calcium channel blocker or long-acting nitrate if necessary.

34
Q

When is revascularization considered in CAD?

A

When two or more drugs fail to achieve acceptable symptom control, revascularization like PCI or CABG may be pursued.

35
Q

What are the steps involved in Percutaneous Coronary Intervention (PCI)?

A

A guide-wire is passed across a coronary stenosis, a balloon is inflated to dilate the stenosis, and a stent is deployed to maintain vessel patency.

36
Q

What is Coronary Artery Bypass Grafting (CABG)?

A

A surgery where stenosed arteries are bypassed using internal mammary, radial arteries, or saphenous vein segments to restore blood flow.

37
Q

Why should intramuscular injections be avoided in angina management?

A

Poor skeletal muscle perfusion in angina patients increases the risk of painful hematoma formation at the injection site.